
Race to Treat Spinocerebellar Ataxia Accelerates as First Commercial Therapy Nears FDA Nod | DataM Intelligence
The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. AUSTIN, TX, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Race to Treat …